1887

Abstract

Summary

Inducibility of β-lactamase activity by cefoxitin was examined in 626 gramnegative clinical isolates selected for amoxycillin and cephalothin resistance. The results indicated that precise identification and cefoxitin sensitivity or resistance could be used to predict the inducibility of β-lactamase. Of 326 organisms from species capable of β-lactamase induction, inductionwas shown in 68% and was predictable from the cefoxitin-sensitivity and identification data. No induction of β-lactamase occurred in the remaining species. Acomparison of β-lactamase activities against cefotaxime, cefoperazone and latamoxef showed that inductionofenzyme activity against cefotaxime and cefoperazone occurred at similar rates. Induction of activity against latamoxef did not occur or was minimal with three bacterialspecies. The data show that of 119 strains of Enterobacteriaceae displaying inducible β-lactamase, 113 would have been reported as unequivocally sensitive to cefotaxime, 109 as sensitive to cefoperazone and 116 as sensitive to latamoxef if the disk-diffusion technique alone hadbeen used. The majority of strains examined produced inducible enzyme and they were moreresistant to the three cephalosporins tested than were the Enterobacteriaceae.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-21-3-203
1986-05-01
2022-05-29
Loading full text...

Full text loading...

/deliver/fulltext/jmm/21/3/medmicro-21-3-203.html?itemId=/content/journal/jmm/10.1099/00222615-21-3-203&mimeType=html&fmt=ahah

References

  1. Barry A L, Thornsberry C. 1980; Susceptibility testing: diffusion test procedures. In Lennette E M. et al. (eds) Manual of clinical microbiology;, 3rd edn. American Society for Microbiology, Washington, D.C.: p 463
    [Google Scholar]
  2. Goering R V, Sanders C C, Sanders W E. 1982; Antagonism of carbenicillin and cefamandole by cefoxitin in treatment of experimental infections inmice. Antimicrobial Agents and Chemotherapy 21:963–967
    [Google Scholar]
  3. Gootz T D, Jackson D B, Sherris J C. 1984; Development of resistance to cephalosporins in clinical strains of Citrobacterspp.. Antimicrobial Agents and Chemotherapy 25:591–595
    [Google Scholar]
  4. Hoffman T A, Cleary T J, Bercuson D H. 1981; Effects of inducible beta-lactamase and antimicrobial resistance upon the activity of newer beta-lactam antibotics against Pseudomonas aeruginosa. Journal of Antibiotics 34:1334–1340
    [Google Scholar]
  5. Jones R N, Barry A L. 1983; Cefoperazone: a review of its antimicrobial spectrum, β-lactamase stability, enzyme inhibition, and other in-vitro characteristics. Reviews of Infectious Diseases 5:(Suppl 1 )S108–S126
    [Google Scholar]
  6. Jones R N. 1984 et al. Disk diffusion testing, quality control guidelines, and antimicrobial spectrum of HR810, a fourth- generation cephalosporin, in clinical microbiology laboratories. Journal of Clinical Microbiology 20:409–412
    [Google Scholar]
  7. Sanders C C. 1982; Inducible beta lactamases in Enterobacteriaceae and Pseudomonas:Problems for the new beta-lactam antibiotics. Infection Control 3:287–289
    [Google Scholar]
  8. Sanders C C, Sanders W E. 1979; Emergence of resistance to cefamandole: possible role of cefoxitin-inducible beta- lactamases. Antimicrobial Agents and Chemotherapy 15:792–797
    [Google Scholar]
  9. Sanders C C, Sanders W E. 1983; Emergence of resistance during therapy with the newer β-lactam antibiotics: role of inducible β-lactamases and implications for the future. Reviews of Infectious Diseases 5:639–648
    [Google Scholar]
  10. Sanders C C, Sanders W E, Goering R V. 1982; In-vitro antagonism of beta-lactam antibiotics by cefoxitin. Antimicrobial Agents and Chemotherapy 21:968–975
    [Google Scholar]
  11. Sykes R B, Bush K. 1983; Interaction of new cephalosporins with β-lactamases and β-lactamase-producing Gram-negative bacilli. Reviews of Infectious Diseases 5:(Suppl 2)S356–S367
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-21-3-203
Loading
/content/journal/jmm/10.1099/00222615-21-3-203
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error